Dual PI3K-δ/γ inhibition, in combination with PD-1 pathway inhibition, resulted in MDSC inhibition and increased CD8+ T-cell infiltration in preclinical models of HNSCC and osteosarcoma (108, 139). Here, PIK3CD is linked to head and neck squamous cell carcinoma.